Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Feb 15, 2008 (Vol. 28, No. 4)

ChemRefer

URL:www.chemrefer.com
  • Useful database
  • Nothing Significant
Another site of interest to chemists is ChemRefer. Encompassing a mountain of chemical and pharmaceutical literature references, ChemRefer provides access to this content through both a very simple search function on the opening page and a more sophisticated search feature internal to the site. At the latter, users can narrow searches by specifying author, title, journal, citation date, publication, and web address. The site is more than just a literature database, however. For example, functions for drawing structures online are available and the drawn structures can be searched across the database. This is a dandy way to access information. An export feature for user-created structures would be a welcome addition. RSS feeds are available, as is a newsletter. A site that will be bookmarked by many a chemist, I’ll wager.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »